CD8+ cell-mediated immune responses: Relation to disease resistance and susceptibility in lentivirus-infected primates

Journal of Medical Primatology

Volumn 26, Issue 3, 1997, Pages 129-138

  Buijs, L ^a   Bogers, W M J M ^a   Eichberg, J W ^a   Heeney, J L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

AIDS; CD57; CTL; HIV; NK cells; SIV

Indexed keywords

LENTIVIRUS; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMAL; ANIMAL DISEASE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; PHYSIOLOGY; PRIMATE; RETROVIRUS INFECTION; REVIEW; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; LENTIVIRUS INFECTIONS; LENTIVIRUSES, PRIMATE; LYMPHOCYTE SUBSETS; PRIMATES;

EID: 0031158271     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1997.tb00044.x     Document Type: Article

References (117)

1. ABIMIKU AG, FRANCHINI G, ALDRICH K, MYAGKIKH M, MARKHAM P, GARD E, GALLO RC, ROBERT-GUROFF M: Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. AIDS Res Hum Retroviruses 11:383-393, 1995,
2. AHMED-ANSARI A, BRODIE AR, FULTZ PN, AVDERSON DC, SELL KW, MCCLURE M: Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhuman primates: Correlation of phenotype with immune function. Am J Primatol 17:107-131, 1989.
3. ALDHOUS MC, WATRET KC, MOK JY, BIRD AC, FROEBEL KS: Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 97:61-67, 1994.
4. ANDERSON RE, SHIBOSKI SC, ROYCE R, JEWELL NP, LANG W, WINKELSTEIN W JR: CD8+ T lymphocytes and progression to AIDS in HIV-infected men: Some observations. AIDS 5:213-215, 1991.
5. AUTRAN B, MAYAUD C, RAPHAEL M, PLATA F, DENIS M, BOURGAIN A, GUILLON JM, DEBRE P, AKOUN G: Evidence for a cytotoxic T lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 2:179-183, 1988.
6. AUTRAN B, LEBLOND V, SADAT-SOWTI B, LEFRRANC E, GOT P, SUTTON L, BINET J, DEBRE P: A soluble factor released by CD8+/CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77:2237-2241, 1991.
7. BAIER M, WERNER A, BANNERT N, METZNER K, KURTH R: HIV suppression by interleukine-16. Nature 378:563, 1995.
8. BASGARA O, POMMERANTZ RG: The role of CD8-positive lymphocytes in the control of HIV-1 infection of peripheral blood mononuclear cells. Immunol Lett 35:83-92, 1993.
9. BELO M, YAGELLO M, GIRARD M, GREENLEE R, DESLANDRES A, BARRE-SINOUSSI F, GLUCKMANN J: Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees. AIDS 5:169-176, 1991.
10. BLACKBOURN DJ, CHUANG LF, KILLAM KF JR, CHUANG RY: Inhibition of simian immunodeficiency virus (SIV) replication by CD8+ cells of SIV infected rhesus macaques: Implications of immunopathogenesis. J Med Primatol 23:343-354, 1994.
11. BOFILL M, JANOSSY G, LEE CA, MACDONALD-BLRNS D, PHILLIPS AN, SABIN C, TIMMS A, JOHNSON MA, KERNOFF PBA: Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV diagnosis. Clin Exp Immunol 88:243-252, 1992.
12. BOLLINGER RC, QUINN TC, LIU AY, STANHOPE PE, HAMMOND SC, VIVEEN R, CLEMENTS MC, SILICIANO RF: Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: Effects on viral replication. AIDS Res Hum Retroviruses 9:1067-1077, 1993.
13. BONAVIDA B, KATZ J, GOTTLIEB M: Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and in AIDS-related complex. J Immunol 137:1157-1163, 1986.
14. BORROW P, LEWICKI H, HAHN B, SHAW GM, OLDSTONE MBA: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viraemia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103-6110, 1994.
15. BOURGAUD I, VlLLEFROY P, BEYER C, AUBERTIN A, LEVY J, VENET A: Cytotoxic T cell response and AIDS-free survival in simian immunodeficiency virus-infected macaques. AIDS 7:S73-S79, 1993.
16. BRENNER BG, DASCAL A, MARGOLESE RG, WAINBERG MA: Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J Leukoc Biol 46:75-83, 1989.
17. BRINCHMANN JE, GAUDERNACK G, VARTDAL F: In vitro replication of HIV-1 in naturally infected CD4+ T Cells is inhibited by rIFNa2 and by a soluble factor secreted by CD8+ activated CD8+ T cells, but not by rIFNbeta, rIFNgamma or recombinant tumor necrosis factor-alpha J Acquir Immune Defic Syndr 4:480-488, 1991.
18. BROLIDEN K, HINKULA J, TOLFVENSTAM T, NIPHUIS H, HEENEY JL: Antibody dependant cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: Comparison of humans and chimpanzees. AIDS 10:1199-1204, 1996.
19. BRINCHMANN JE, GAUDERNACK G, VARTDAL F: CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble factor. J Immunol 2961-2966, 1990.
20. BURCHAM J, MARMOR M, DUBIN N, TINDALL B, COOPER DA, BERRY G, PENNY R: CD4+ is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 5:365-372, 1991.
21. CAI Q, HUANG, RAPPOCHIOLO G, RINALDO CR JR: Natural Killer responses in homosexual man with early HIV infection. J Acquir Immune Defic Syndr 3:669-676, 1990.
22. CAO Y, QIN L, ZHANG L, SAFRIT J, Ho D: Virologie and immunologic characterization of long term survivors of human immunodeficiency virus type 1 infection. New Eng J Med 332:201-208, 1995.
23. CASTRO BA, WALKER CM, EICHBERG JW, LEVY JA: Suppression of human immunodeficiency virus by CD8+ cells from infected and uninfected chimpanzees. Cell Immunol 132:246-255, 1991.
24. CHEYNIER R, LANGLADE-DEMOYEN, MARESCOT M, BLANCHE S, BLONDINE G, WAIN-HOBSON S, GRISCELLI C, VILMER E, PLATA R: Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur J Immunol 22:2211-2217, 1992.
25. COCCHI F, DEVICO AL, GARZINO-DEMO A, ARYA SK, GALLO RC, LUSSO P: Identification of RANTES, MIP-lalpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ Tcells. Science 270:1811-1815, 1995.
26. EICHBERG JW, MONTIEL MM, MORALE BA, KING DE, CHANH TC, KENNEDY RC, DREESMAN GR: Lymphocyte subsets in chimpanzees. Lab Anim Sci 38:197-198, 1988.
27. ENNEN J, FINDEKLEE H, DITTMAR MT, NORLEY S, ERNST M, KURTH R: CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci USA 91:7207-7211, 1994.
28. ENNEN J, NORLEY S, KURTH R: The activated CD8 T lymphocyte-derived immunodeficiency-virus-suppressing lymphokine in African green monkeys. Res Immunol 145(8 9):647-653, 1994.
29. ERICKSON A, WALKER CM: An epitope in the V1 domain of the simian immunodeficiency virus gp120 protein is recognized by CD8+ CTL from an SIV-infected rhesus macaque. J Virol 68:2756-2759, 1994.
30. FERRARI G, PLACE CA, AHEARNE PA, NEGIDA SM JR, ARTHUR LO, BOLOGNESI DP, WEINHOLD KJ: Comparison of anti-HIV l ADCC reactivities in infected humans and chimpanzees. J Acquir Immune Defic Syndr 7:325-331, 1994.
31. FERRARI G, OTTINGER J, PLACE C, NIGIDA SM JR, ARTHUR LO, WEINHOLT KJ: The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. AIDS Res Hum Retroviruses 9:647-656, 1993.
32. GALLIMORE A, CRANAGE M, COOK N, ALMOND N, BOOTMAN J, RUD E, SILVERA P, DENNIS M, CORCORAN T, STOTT J, MCMICHAEL A, GOTCH F: Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1:1167-1173, 1995.
33. T. the prognostic value of low CD4+ T cells levels: Results of 6 years of follow-up. J Acquir Immune Defic Syndr 6:904-912, 1993.
34. GIORGI JV, Ho H, HARJI K, CHOU C, HULTIN LE, O'ROURKE S, PARK L, MARGOLICK JB, FERBAS J, PHAIR JP, THE MULTICENTRE AIDS COHORT GROUP: CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of HLA-DR +CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 170:775-781, 1994.
35. GOLDING H, ROBEY FA, GATESII FT, LINDER W, BEINING PR, HOFFMAN T, GOLDING B: Identification of homologous re- gions in human deficiency virus I gp41 and human MHC class II beta-1 domain. J Exp Med 167:914-923, 1988.
36. GOTCH FM, NIXON DF, ALP N, MCMICHAEL AJ, BORYSIEWYCZ LK: High frequency of memory and effector gag-specific T lymphocytes in HIV infected individuals Int Immun 2:707-712, 1990.
37. GREEN DR, WEBB DR: Saying the "S" word in public. Immunol Today 11:523-525, 1993.
38. TEN HAAFT P, CORNELISSEN M, GOUDSMIT J, KOORNSTRA W, DUBBES R, NIPHUIS H, PEETERS M, THIRIART C, BRUCK C, HEENEY JL: Virus load in chimpanzees infected with human immunodeficiency virus type 1: Effect of pre-exposure vaccination. J Virol 76:1015-1020, 1995.
39. HARRER T, JASSOY C, HARRER E, PAUL JOHNSON R, WALKER BD: Induction of HIV-1 replication in a chronically infected T-cell line by cytotoxic T lymphocytes. J Acquir Immune Defic Syndr 6:865-871, 1993.
40. HIRSCH VM, DAPOLITO G, JOHNSON PR, ELKINS WR, LONDON WT, MONTALI RJ, GOLDSTEIN S, BROWN C: Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 69:955-967, 1995.
41. HEENEY JL, VAN ELS C, DE VRIES P, TEN HAAFT P, OTTING N, KOORNSTRA W, BOES J, DUBBES R, NIPHUIS H, DINGS M, CRANAGE M, NORLEY S, JONKER M, BONTROP R, OSTERHAUS A: Major histocompatibility complex class I associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 180:769-774, 1994.
42. HEENEY JL: AIDS: A disease of impaired Th cell renewal? Immunol Today 16:515-520, 1995.
43. HEENEY JL, HOLTERMAN L, TEN HAAFT P, DUBBES R, KOORNSTRA W, TEEUWSEN V, BOURQUIN P, NORLEY S, NIPHUIS H: Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retroviruses 10:117-121, 1994.
44. VON HERRATH M, OLDSTONE MBA, Fox SF: Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154:5582-5589, 1995.
45. Ho M, ARMSTRONG J, MCMAHON D, PAZIN G, LI HUANG X, RINALDO C, WHITESIDE T, TRIPOLI C, LEVINE G, MOODY D, OKARMA T, ELDER E, GUPTA P, TAUXE N, TORPEY D, HERBERMAN R: A phase I study of adoptive transfer of autologous CD8+ lymphocytes in patients with ARC or AIDS. Blood 81:2093-2101, 1993.
46. Ho H, HULTIN LE, MITSUYASU RT, MATUD JL, HAUSNER MA, BOCKSTORE D, CHOL C, O'ROURKE S, TAYLOR JMG, GIORDI J: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA antigens. J Immunol 150:3070-3079, 1993.
47. HOFFENBACH A, LANGLADE-DEMOYEN P, DADAGLIO G, VILMER E, MICHEL F, MAYAUD C, AUTRAN B, PLATA F: Unusual high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452-462, 1989.
48. HUSCHL B, EIBL MM, MANNHALTER JW: CD3, CD8 double positive cells from HIV-1 infected chimpanzees show group specific inhibition of HIV-replication. AIDS Res Hum Retroviruses 9:405-413, 1993.
49. JOAG SV, ADAMS RJ, FORESMAN L, GALBREATH D, ZINC MC, PINSON DM, MCCLURE H, NARAYAN O: Early activation of PBMC and appearance of antiviral CD8+ cells influence the prognosis of SIV-induced disease in rhesus macaques. J Med Primatol 23:108-116, 1994.
50. JOLY P, GUILLON J, MAYAUD C: Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol 143:2193-2201, 1989.
51. KANNAGI M, MATSUDA T, HATTORI T, KANOH T, NASU K, YAMAMOTO N, HARADA S: Interference with human immunodeficiency virus replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virol 2:3399-3406, 1990.
52. cpz-ant. J Infect Dis 172:957-963, 1995.
53. KESTENS L, VANHAM G, GIGASE P, YOUNG G, HANNET I, VANLANGENDONK F, HULSTAERT F, BACH BA: Expression of activation antigens, HLA and CD38 on CD8 lymphocytes during HIV-1 infection. AIDS 6:793-797, 1992.
54. KLIMAS NG, PATARCA R, WALLING J, GARCIA R, MAYER V, MOODY D, OCARMA T, FLETCHER M: Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CDS T cells and interleukin-2 infusion. AIDS 8:1073-1081, 1994.
55. KNUCHEL M, BEDNARIK DP, CHIKKALA N, ANSARI A: Biphasic in vitro regulation of retroviral replication by CD8+ cells from nonhuman primates. J Acquir Immune Defic Syndr 7:438-446, 1994.
56. KOENIG S, CONLEY AJ, BREWAH YA, JONES GM, LEATH S, BOOTS LJ, DAVEY V, PANTALEO G, DEMAREST JF, CARTER C, WANNEBO C, YANNELLI JR, ROSENBERG SA, CLIFFORD LANE H: Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1:330-336, 1995.
57. KOOPMAN G, WEVER PC, RAMKEMA MD, BELLOT F, KEEHNEN RJM, TEN BERGEN RJM, PALS ST: Expression of granzyme B by CTL in lymph nodes of HIV infected patients. AIDS Res Hum Retroviruses in press.
58. KOUP RA, SAFRIT JT, CAO Y, ANDREWS CA, MCLEOD G, BORKOWSKY W, FARTHING C, Ho DA: Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type I syndrome. J Virol 68:4650-4655, 1994.
59. KURTH R, NORLEY S: Simian immunodeficiency viruses of African green monkeys. Curr Top Microbiol Immunol 188:21-33, 1994.
60. LANDAY AL, MACKEWICZ CE, LEVY JA: An activated CD8+ T cell phenotype correlates with anti HIV activity and asymptomatic clinical status. Clin Immunol Immunopath 69:106-116, 1993.
61. LANGLADE-DEMOYEN P, NGO-GIANG-HUONG N, FERCHAL F, OKSENHENDLER E: HIV nef-specific cytotoxic T lymphocytes in noninfected heterosexual contacts of HIV-patients. J Clin Invest 93:1293-1297, 1994.
62. LANZAVECCHIA A: Harming and protecting responses to HIV Res Immunol 140:99-103, 1989.
63. LEE T, SHEPPARD HW, REISS M, DONDERO D, OSMOND D, BUSCH MP: Circulating HIV-1-infected cell burden from seroconversion to AIDS: Importance of post seroconversion viral load on disease course. J Acquir Immune Defic Syndr 7:381-388, 1994.
64. LETVIN NL, DANIEL MD, SEHGAL PK, DESROSIERS RC, HUNT RD, WALDRON RM, MACKEY JJ, SCHMIDT DK, CHALIFOUX LV, KING NW: Induction of AIDS-like disease in macaques with T-cell tropic retrovirus STLV-III. Science 230-71-73, 1985.
65. LOMBARDI G, SIDHU S, BACHELOR R, LECHNER R: Anergic T cells as suppressor cells in vitro. Science 264:1587-1589, 1994.
66. LYERLY HK, MATHEWS TJ, LANGLOIS AJ, BOLOGNESI DP, WEINHOLD KJ: HTLV III gp120 bound to CD4 determinants on normal lymphocytes serves as target for immune attack. Proc Natl Acad Sci USA 84:4601-4605, 1987.
67. LEWIS DE, PUCK JM, BABCOCK GF, RICH RR: Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis 151:555-559, 1985.
68. LEVY JA, MACKEWICZ CE, BARKER E: Controlling HIV pathogenesis: The role on non-cytotoxic anti-HIV response of CD8+T cells. Immunol Today 17:217-224, 1996.
69. LOHMAN BL, MCCHESNEY MB, MILLER CJ, MCGOWAN E, JOYE SM, VAN ROMPAY KKA, REAY E, ANTIPA L, PEDERSEN NC, ANSARI A, MARTHAS ML: A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol :7021-7029, 1994.
70. MACKEWITZ CA, CHANG LC, LIFSON ID, LEVY JA: Non-cytolytic CD8 T-cell responses in primary HIV-1 infection. Lancet 344:1671-1673, 1994.
71. MACKEWICZ CE, ORTEGA H, LEVY JA: Effect of cytokines on HIV replication in CD4+ lymphocytes: Lack of identity with the CD8+ cell antiviral factor. Cell Immunol 153:329-343, 1994.
72. MARGOLICK JB, SCOTT ER, DAKA N, SAAH AJ: Flow cytometric analysis of gamma delta T cells and natural killer cells in HIV-1 infection. Clin Imm Immunopath 58:126-138, 1991.
73. MELLORS JW, KINGSLY LA, RINALDO CR JR, TODD JA, HOO BS, KOKKA RP, GUPTA P: Quantization of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573-579, 1995.
74. MILLER MD, LORD CI, STALLARD V, MAZZARRA GP, LETVIN NL: Gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. J Immunol 144:122-128, 1989.
75. NARA P, HATCH W, KESSLER J, KELLIHER J, CARTER S: The biology of human immunodeficiency virus-1 in the chimpanzee: In vivo and in vitro correlations. J Med Primatol 18:343-355, 1989.
76. OHKAWA S, WILSON LA, LAROSA G, JAVAHERIAN K, MARTIN LN, MURPHEY-CORB M: Immune responses induced by prototype vaccines for AIDS in rhesus monkeys. AIDS Res Human Retroviruses 10:27-38, 1994.
77. OKSENHENDLER E, AUTRAN B, GOROCHOV G, D'AGAY MF, SELIGMANN M, CLAUVEL J: CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet 340:207-208, 1992.
78. PLAEGER-MARSHALL S, SPINA CA, GIORDI JV, MITSUYASU R, WOLFE P, GOTTLIEB M, BEALL G: Alterations in cytotoxic and phenotypic subsets of natural killer cells in AIDS. J Clin Immunol 7:16, 1987.
79. PLATA F, DADAGLIO G, CHENCINER N, HOFFENBACH N, WAIN-HOBSON S, MICHEL F, LANGLADE-DEMOYEN P: Cytotoxic T lymphocytes in HIV-induced disease: Implications for therapy and vaccination. Immunodefic Rev 1:2227-2246, 1987.
80. PHILLIPS AN, SABIN CA, ELFORD J, BOFILL M, LEE CA, JANOSSY G: CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow up. AIDS 7:975-980, 1993.
81. POWELL JD, YEHUDA-COHEN T, VILLINGER F, MCCLURE HM, SELL KW, AHMED-ANSARI A: Inhibition of SIV/SMM replication by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys. J Med Primatol 19:239-249, 1990.
82. POWELL JD, BERDNARIK DP, FOLKS TM, JEHUDA-COHEN T, WILLINGER F, SELL KW, AHMED-ANSARI A: Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from nonhuman primates. Clin Exp Immunol 91:473-481, 1993.
83. POWELL JD, MCCLURE HM, ANDERSON D, FULTZ PN, SELL KW, AHMED-ANSARI A: Phenotypic and functional differences in NK and LAK cells in the peripheral blood of sooty mangabeys and rhesus macaques. Cell Immunol 124:107-118, 1989.
84. RAPPOCCIOLO G, ALLAN JS, EICHBERG JW, CHANH TC: A comparative study of natural killer activity, lymphoproliferation and cell phenotypes in nonhuman primates. Vet Pathol 29:53-59, 1992.
85. REIMANN KA, TENNER-RACZ K, RACZ P, MONTEFIORI DC, YASUTOMI Y, LIN W, RANSIL BJ, LETVIN NL: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68:2362-2370, 1994.
86. RIVIERE Y, TANNEAU-SALVADORI F, REGNAULT A, LOPEZ O, SANSONETTI P, GUY B, KIENY MP, FOURNELL JJ, MONTAGNIER L: Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus. Res Immunol 110-115, 1989.
87. ROSENBERG YJ, ZACK PM, LEON EC, WHITE BD, PAPERMASTER SF, HALL E, GREENHOUSE JJ, EDDY GA, LEWIS MG: Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. AIDS Res Human Retroviruses 10:863-872, 1994.
88. ROWLAND-JONES S, NIXON DF, ALTHOUS MC, GOTCH F, ARIYOSHI K, HALLAM N, KROLL JS, FROEBEL K, MCMICHAEL A: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860-861, 1993.
89. ROWLAND-JONES S, SUTTON J, ARIYOSHI K, DONG T, GOTCH F, MCADAM S, WHITBYE D, SABALLY S, GALLIMORE A, CORRAH T, TAKIGUCHI M, SCHULZ T, MCMICHAEL A, WHITTLE H: HIV specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med. 1:59-64, 1995.
90. SADAT-SOWTI B, DEBRE P, IDZIOREK T, GUILLON J, HADIDA F, OKZENHENDLER E, KATLAMA C, MAYAUD C, AUTRAN B: A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 21:737-741, 1991.
91. SCHELLEKENS PTA, ROOS MT: in: Immunofenotypering in de diagnostiek: 145-154, 1994.
92. SETHI KK, NAHER H, STROEHMANN I: Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic cell clones. Nature 335-178-181, 1988.
93. SHEN L, CHEN ZW, LETVIN N: The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants. J Immunol 153:5849-5854, 1994.
94. agm infection in the African green monkey natural host. J Acquir Immune Defic Syndr 8:217-226, 1995.
95. SIRIANNI MC, SODDUS S, MALLORNI W, AIANCIA G, AIUTI F: Mechanism of defective natural killer activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol 140:2565, 1988.
96. STITES DP, Moss AR, BACCHETTI P, OSMOND D, MCHUGH TM, JANE WANG Y, HERBERT S, COLFER B: Lymphocyte subset analysis to predict progression to AIDS in a co- hort of homosexual men in San Francisco. Clin Immunol Immunopath. 52:96-103, 1989.
97. TENNER-RACZ K, RACZ P, THOME C, MEYER CG, ANDERSON PJ, SCHLOSSMAN SF, LETVIN NL: Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunology virus-1-infected patients Am J Pathol 142:1750-1758, 1993.
98. TERAO K, ROSE LM, SACKETT GP, CLARK EA: Development of lymphocyte subsets in pigtailed macaques. Hum Immunol 21:33-48, 1988.
99. TORPEY D III, HUANG X, ARMSTRONG J, HO M, WHITESIDE T, MCMAHON D, PAZIN G, HERBERMAN R, GUPTA P, TRIPOLI C, MOODY D, OKARMA T, ELDER E, RINALDO C JR: Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: Lymphocyte subsets and cytolytic activity. Clin Immunol Immunopath 68:263-272, 1993.
100. TSUBOTA H, LORD CI, WATKINS DI, MORIMOTO C, LETVIN NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 169:1421-1434, 1989.
101. TYLER DS, KIM LYERLY H, WEINHOLD KJ: Anti HIV-1 ADCC. AIDS Res Hum Retroviruses 5:557-563, 1988.
102. VANHAM G, KESTENS L, PENNE G, GOILAV C, GIGASE P, COLEBUNDERS, VANDENBRUANE M, GOEMAN J, VAN DER GROEN G, CEUPPENS JL: Subset markers of CD8+ cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 11:6:345-356, 1991.
103. VENET A, BOURGAULT I, AUBERTIN A-M, KIENY M-P, LEVY J-P: Cytotoxic T-lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. J Immunol 148:2899-2908, 1992.
104. VUILLIER F, BIANCO NE, MONTAGNIER L, DIEGHEIRO G: Selective depletion of low density CD8+/CD16+ lymphocytes during HIV-infection. AIDS Res Hum Retroviruses 4:121, 1989.
105. VOWELS BR, GERSHWIN ME, GARDNER MB, MCGRAW TP: Natural killer cell activity of rhesus macaques against retrovirus-pulsed CD4+ target cells. AIDS Res Hum Retroviruses 6:905-918, 1990.
106. VOWELS BR, GERSHWIN ME, GARDNER MB, AHMED-ANSARI A, MCGRAW TP: Characterization of simian immunodeficiency virus (SIV)-specific T-cell-mediated cytotoxic response of infected rhesus macaques. AIDS 3:785-792, 1989.
107. WALKER CM, THOMSON-HONNEBIER GA, HSUEH FC, ERICKSON AL, PAN L, LEVY J: CD8+ T cells from HIV-a-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137:420-428, 1991.
108. WALKER CM, MOODY DJ, STITES DP, LEVY JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566, 1986.
109. WALKER CM, LEVY JA: A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunol 66:628-630, 1989.
110. WALKER CM, ERICKSON AL, HSUEH FC, LEVY JA: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a non-cytotoxic mechanism. J Virol 65:5921-5927, 1991.
111. WALKER BD, CHAKRABARTI S, Moss B, PARADIS TJ, FLYNN T, DURNO AG, BLUMBERG RS, KAPLAN JC, HIRSCH MS, SCOOLEY RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348, 1987.
112. WIVIOT LD, WALKER CM, LEVY JA: CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell Immunol 128:628-634, 1990.
113. YASUTOMI Y, REIMANN KA, LORD CI, MILLER MD, LETVIN NL: Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67:1701-1711, 1993.
114. WATANABE M, RINGLER DJ, FULTZ PN, MCKEY JJ, BOYSON JE, LEVINE CG, LETVIN NL: A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J Virol 65:3344-3348, 1991.
115. YAMAMOTO H, HIRAYAMA M, GENYEA C, KAPLAN J: TGF beta mediates natural suppressor activity of IL-2 activated lymphocytes. J Immunol 3842-3847, 1994.
116. ZACHAR V, MIKULACKY M, MAYER V, MACKAY I, FRAZER I: A biometrical view on normal values of CD4 and CD8 lymphocyte counts in peripheral blood. Pathology 20:358-360, 1988.
117. ZARLING JM, LEDBETTER JA, SIAS J, FULTZ PN, EICHBERG JW, GJERSET G, MORAN PA: HIV-infected humans, but not chimpanzees have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J Immunol 144:2992-2998, 1990.